Literature DB >> 21939734

Transcranial sonography findings in spinocerebellar ataxia type 3 (Machado-Joseph disease): a cross-sectional study.

José Luiz Pedroso1, Edson Bor-Seng-Shu2, Andre Carvalho Felício3, Pedro Braga-Neto3, Manoel Jacobsen Teixeira2, Orlando Graziani Barsottini3.   

Abstract

Few studies on transcranial brain sonography have been performed in hereditary and non-hereditary ataxias. The objective of the present study was to report transcranial brain sonography findings in a sample of clinically and molecularly proven Machado-Joseph disease patients and to compare these data against those of an age- and gender-matched control group. A cross-sectional study on transcranial brain sonography was conducted in 30 Machado-Joseph disease patients. Transcranial brain sonography was performed by an experienced sonographer blinded to the clinical, genetic, and neuroimaging data. The results were compared with those of a control group of 44 healthy subjects matched for age and gender. The sonographic findings were also correlated with clinical features and genetic data in Machado-Joseph disease group. A significantly higher frequency of substantia nigra and lenticular nucleus hyperechogenicity was found in the Machado-Joseph disease group compared to an age- and gender-matched healthy control group (p<0.001). The substantia nigra echogenic area proved to be the best predictor for differentiating cases from controls. Third and lateral ventricles were significantly larger in the Machado-Joseph disease patients than in the control subjects. No significant correlations were found between transcranial brain sonography findings and Machado-Joseph disease demographic/clinical data. Transcranial brain sonography findings in Machado-Joseph disease patients differed significantly to those in age- and gender-matched controls. Substantia nigra hyperechogenicity occurred frequently in Machado-Joseph disease patients and was found to be the best predictor for differentiating cases from controls. Additionally, this data describes the occurrence of brain atrophy in Machado-Joseph disease group.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21939734     DOI: 10.1016/j.neulet.2011.09.006

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Neurophysiological studies and non-motor symptoms prior to ataxia in a patient with machado-joseph disease: trying to understand the natural history of brain degeneration.

Authors:  José Luiz Pedroso; Edson Bor-Seng-Shu; Pedro Braga-Neto; Rodrigo Souza Ribeiro; Márcio Luiz Escorcio Bezerra; Lucila B F do Prado; Ilza Rosa Batista; Helena Alessi; Manoel Jacobsen Teixeira; Gilberto Mastrocola Manzano; Gilmar Fernandes do Prado; Orlando Graziani Povoas Barsottini
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

Review 2.  Sleep Disorders in Hereditary Ataxias.

Authors:  Lucio Huebra; Fernando Morgadinho Coelho; Flávio Moura Rezende Filho; Orlando G Barsottini; José Luiz Pedroso
Journal:  Curr Neurol Neurosci Rep       Date:  2019-07-25       Impact factor: 5.081

3.  Substantia nigra echogenicity in hereditary ataxias with and without nigrostriatal pathology: a pilot study.

Authors:  Patricia Martínez-Sánchez; Rubén Cazorla-García; Irene Sanz-Gallego; Elisa Correas-Callero; Irene Pulido-Valdeolivas; Javier Arpa
Journal:  Cerebellum       Date:  2015-06       Impact factor: 3.847

Review 4.  Movement Disorders in Autosomal Dominant Cerebellar Ataxias: A Systematic Review.

Authors:  Malco Rossi; Santiago Perez-Lloret; Daniel Cerquetti; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2014-06-06

5.  Dopamine transporter imaging using 99mTc-TRODAT-1 SPECT in Parkinson's disease.

Authors:  Edson Bor-Seng-Shu; Andre C Felicio; Pedro Braga-Neto; Ilza Rosa Batista; Wellingson Silva Paiva; Daniel Ciampi de Andrade; Manoel Jacobsen Teixeira; Luis Augusto Franco de Andrade; Orlando Graziani Povoas Barsottini; Ming Chi Shih; Rodrigo A Bressan; Henrique Ballalai Ferraz
Journal:  Med Sci Monit       Date:  2014-08-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.